LH
Price
$243.72
Change
-$3.52 (-1.42%)
Updated
Jul 18 closing price
Capitalization
18.37B
3 days until earnings call
RMD
Price
$258.69
Change
+$0.79 (+0.31%)
Updated
Jul 21, 10:41 AM (EDT)
Capitalization
29.13B
10 days until earnings call
Interact to see
Advertisement

LH vs RMD

Header iconLH vs RMD Comparison
Open Charts LH vs RMDBanner chart's image
Laboratory
Price$243.72
Change-$3.52 (-1.42%)
Volume$573.38K
Capitalization18.37B
ResMed
Price$258.69
Change+$0.79 (+0.31%)
Volume$200
Capitalization29.13B
LH vs RMD Comparison Chart in %
Loading...
LH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LH vs. RMD commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LH is a Hold and RMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (LH: $243.72 vs. RMD: $257.89)
Brand notoriety: LH and RMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LH: 81% vs. RMD: 111%
Market capitalization -- LH: $18.37B vs. RMD: $29.13B
LH [@Medical Specialties] is valued at $18.37B. RMD’s [@Medical Specialties] market capitalization is $29.13B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LH’s FA Score shows that 1 FA rating(s) are green whileRMD’s FA Score has 2 green FA rating(s).

  • LH’s FA Score: 1 green, 4 red.
  • RMD’s FA Score: 2 green, 3 red.
According to our system of comparison, RMD is a better buy in the long-term than LH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LH’s TA Score shows that 5 TA indicator(s) are bullish while RMD’s TA Score has 6 bullish TA indicator(s).

  • LH’s TA Score: 5 bullish, 5 bearish.
  • RMD’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RMD is a better buy in the short-term than LH.

Price Growth

LH (@Medical Specialties) experienced а -2.36% price change this week, while RMD (@Medical Specialties) price change was +1.37% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.11%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was -1.25%.

Reported Earning Dates

LH is expected to report earnings on Jul 24, 2025.

RMD is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-0.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RMD($29.1B) has a higher market cap than LH($18.4B). LH has higher P/E ratio than RMD: LH (49.97) vs RMD (31.34). RMD YTD gains are higher at: 13.267 vs. LH (6.895). RMD has higher annual earnings (EBITDA): 1.43B vs. LH (1.35B). LH has more cash in the bank: 537M vs. RMD (210M). RMD has less debt than LH: RMD (1.39B) vs LH (5.95B). LH has higher revenues than RMD: LH (12.2B) vs RMD (4.5B).
LHRMDLH / RMD
Capitalization18.4B29.1B63%
EBITDA1.35B1.43B94%
Gain YTD6.89513.26752%
P/E Ratio49.9731.34159%
Revenue12.2B4.5B271%
Total Cash537M210M256%
Total Debt5.95B1.39B428%
FUNDAMENTALS RATINGS
LH vs RMD: Fundamental Ratings
LH
RMD
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
3560
SMR RATING
1..100
7338
PRICE GROWTH RATING
1..100
5522
P/E GROWTH RATING
1..100
9162
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LH's Valuation (14) in the Servicestothe Health Industry industry is in the same range as RMD (20) in the Medical Specialties industry. This means that LH’s stock grew similarly to RMD’s over the last 12 months.

LH's Profit vs Risk Rating (35) in the Servicestothe Health Industry industry is in the same range as RMD (60) in the Medical Specialties industry. This means that LH’s stock grew similarly to RMD’s over the last 12 months.

RMD's SMR Rating (38) in the Medical Specialties industry is somewhat better than the same rating for LH (73) in the Servicestothe Health Industry industry. This means that RMD’s stock grew somewhat faster than LH’s over the last 12 months.

RMD's Price Growth Rating (22) in the Medical Specialties industry is somewhat better than the same rating for LH (55) in the Servicestothe Health Industry industry. This means that RMD’s stock grew somewhat faster than LH’s over the last 12 months.

RMD's P/E Growth Rating (62) in the Medical Specialties industry is in the same range as LH (91) in the Servicestothe Health Industry industry. This means that RMD’s stock grew similarly to LH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LHRMD
RSI
ODDS (%)
Bullish Trend 4 days ago
54%
Bearish Trend 4 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
64%
Momentum
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
62%
MACD
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
51%
Bullish Trend 4 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
48%
Bullish Trend 4 days ago
62%
Advances
ODDS (%)
Bullish Trend 5 days ago
59%
Bullish Trend 4 days ago
62%
Declines
ODDS (%)
Bearish Trend 11 days ago
50%
Bearish Trend 7 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
75%
Aroon
ODDS (%)
Bullish Trend 4 days ago
45%
Bullish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
LH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SFYF48.580.12
+0.24%
SoFi Social 50 ETF
SAWG20.57N/A
N/A
AAM Sawgrass US Large Cap Quality Growth ETF
JQUA60.20-0.02
-0.03%
JPMorgan US Quality Factor ETF
NUDM35.05-0.03
-0.09%
Nuveen ESG Intl Dev Mkts Eq ETF
AVXC56.97-0.47
-0.81%
Avantis Emerging Markets Ex-Chn Eq ETF

LH and

Correlation & Price change

A.I.dvisor indicates that over the last year, LH has been closely correlated with DGX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if LH jumps, then DGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LH
1D Price
Change %
LH100%
-1.42%
DGX - LH
67%
Closely correlated
-0.76%
RVTY - LH
52%
Loosely correlated
-2.36%
STE - LH
52%
Loosely correlated
+0.44%
SYK - LH
51%
Loosely correlated
+0.13%
CRL - LH
50%
Loosely correlated
-1.42%
More

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with RVTY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+0.57%
RVTY - RMD
42%
Loosely correlated
-2.36%
IDXX - RMD
39%
Loosely correlated
-0.79%
SYK - RMD
37%
Loosely correlated
+0.13%
LH - RMD
35%
Loosely correlated
-1.42%
MTD - RMD
35%
Loosely correlated
-0.90%
More